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Abstract
Background: Associations of proteinuria with low-level urinary cadmium (Cd) are currently interpreted as the sign
of renal dysfunction induced by Cd. Few studies have considered the possibility that these associations might be
non causal and arise from confounding by factors influencing the renal excretion of Cd and proteins.
Methods: We examined 184 healthy male workers (mean age, 39.5 years) from a zinc smelter (n = 132) or a
blanket factory (n = 52). We measured the concentrations of Cd in blood (B-Cd) and the urinary excretion of Cd
(U-Cd), retinol-binding protein (RBP), protein HC and albumin. Associations between biomarkers of metal exposure
and urinary proteins were assessed by simple and multiple regression analyses.
Results: The medians (interquartile range) of B-Cd (μg/l) and U-Cd (μg/g creatinine) were 0.80 (0.45-1.16) and 0.70
(0.40-1.3) in smelter workers and 0.66 (0.47-0.87) and 0.55 (0.40-0.90) in blanket factory workers, respectively.
Occupation had no influence on these values, which varied mainly with smoking habits. In univariate analysis,
concentrations of RBP and protein HC in urine were significantly correlated with both U-Cd and B-Cd but these
associations were substantially weakened by the adjustment for current smoking and the residual influence of
diuresis after correction for urinary creatinine. Albumin in urine did not correlate with B-Cd but was consistently
associated with U-Cd through a relationship, which was unaffected by smoking or diuresis. Further analyses
showed that RBP and albumin in urine mutually distort their associations with U-Cd and that the relationship
between RBP and Cd in urine was almost the replicate of that linking RBP to albumin
Conclusions: Associations between proteinuria and low-level urinary Cd should be interpreted with caution as
they appear to be largely driven by diuresis, current smoking and probably also the co-excretion of Cd with
plasma proteins.
Introduction
Cadmium (Cd) is a widespread pollutant that accumu-
lates in the soil, the food chain and ultimately in the
human body. Other major sources of exposure to Cd
are cigarette smoking and the use or production of Cd
in various industrial settings. Cd is a highly toxic metal
which at high doses can cause damage on virtually all
organs and biological systems. At current human expo-
sure levels in the industry or environment, it is assumed
that Cd primarily damages the kidneys and especially
the proximal tubular cells where the metal selectively
concentrates. The hallmark of Cd nephrotoxicity is an
increased urinary excretion of low-molecular-weight
(LMW) proteins such as b2-microglobulin, retinol-bind-
ing protein (RBP) or protein HC. This increased excre-
tion of LMW proteins in urine referred to as “tubular
proteinuria” results from a defective protein reabsorp-
tion by the damaged tubular cells [1-3].
Studies among industrial workers and populations liv-
ing in heavily polluted areas have clearly shown that Cd
causes tubular dysfunction in a dose-dependent manner,
the tubular proteinuria developing only when the renal
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workers exposed mainly by inhalation, the critical con-
centration of Cd in renal cortex from which tubular
proteinuria is likely to develop has been estimated at
approximately 200 ppm (μg/g wet weight of renal cor-
tex) [4]. The corresponding threshold level for urinary
Cd, an indicator of the Cd body burden in industrial
workers, has been estimated at 10 μg/creatinine [5,6].
This U-Cd threshold level has been confirmed in a
recent study, which estimated the U-Cd benchmark
dose for the LMW proteinuria induced by Cd at 12-13
μg/g creatinine with a lower confidence interval limit of
about 5-6 μg/g creatinine [7].
While surveys among Cd workers have derived rather
consistent estimates of U-Cd threshold for the develop-
ment of LMW proteinuria, studies among the general
population have with time reported increasingly lower
U-Cd threshold values despite the use of the same renal
biomarkers [8-10]. Some studies have even derived U-
Cd threshold levels within the range of values now pre-
vailing in industrialized countries [11,12], which suggests
that a substantial fraction of the human population
m i g h tb ea tr i s ko fC dn e p h r o t o x i c i t y .R e c e n ts t u d i e s
even suggest that the cumulative exposure of the general
population to Cd might increase the risks of chronic
renal diseases [13,14].
A possibility, however, which has received little atten-
tion is that associations between urinary Cd and renal
markers at very low exposure levels might not be causal
but simply reflect the elimination of Cd by the kidneys
and in particular the co-excretion of the metal with
urinary proteins. Because most Cd circulating in plasma
is bound to proteins and especially to the LMW metal-
lothionein, a variation in the tubular reabsorption of
these LMW proteins in health or disease should una-
voidably result in an increased co-excretion of Cd and
LMW proteins in urine [15]. There is indeed no reason
to believe that the renal handling of proteins binding Cd
would be different from that of other plasma proteins
apart some differences related to the size and charge,
which are the main factors governing the renal handling
of proteins. Other important confounders which also
need to be carefully evaluated in causal inference are
the diuresis and chronic smoking, which is a contributor
to Cd exposure but also to renal dysfunction [7,16-19].
The objective of the current study focused on workers
with low exposure to Cd was to further explore the fac-
tors that might confound the associations between Cd
and proteins in urine. Screening for tubular proteinuria
was based on the measurement of RBP and protein HC
in urine, two reliable biomarkers for screening tubular
dysfunction induced by Cd. Different models were built
to detect the confounding effects which might arise
from current or cumulative smoking and from an
insufficient adjustment for diuresis. We also measured
urinary albumin to identify possible co-excretion
mechanisms related to changes in the filtered load and
tubular uptake of plasma proteins.
Materials and methods
Study population
The studied population included 134 healthy male
workers, who had been working in the zinc smelter of
Ghazaouet in Algeria. In 2009 when the workers were
examined, the smelter annual production was of 36.000
tons of zinc and 72.000 tons of sulphuric acid. The pro-
duction of Cd ceased in 1999 and about half of the stu-
died workers were not yet employed in the plant at that
time. The reference group was constituted of 52 male
workers from an acrylic blanket factory located in Tlem-
cen, a city 60 km from Ghazaouet. Biological data and
information about the duration of employment and the
smoking history were obtained in the framework of the
workers’ health surveillance programme that was imple-
mented in each factory in order to comply with the reg-
ulation. These data were sent anonymously by the
factory heath care units.
Protocol
Samples of urine (untimed samples) and blood for metal
and protein analyses were collected in the framework of
the periodic medical surveillance of workers. Cd was
measured in urine by means of inductively coupled
argon plasma mass spectrometry (ICP-MS) with an Agi-
lent 7500 instrument. Briefly, urine specimens (500 μl)
were diluted quantitatively 1+9 with a HNO3 1%, HCl
0.5% solution containing Sc, Ge, Rh and Ir as internal
standards. The detection and quantification limits were
0.02 and 0.05 μg/l, respectively. The laboratory has per-
formed successfully in external quality assessment pro-
grammes of the Institute for Occupational,
Environmental and Social Medicine of the University of
Erlangen, Germany (G-EQUAS programme) and in the
PCI and QMEQUAS programmes of the “Institut
National de Santé Publique”,Q u é b e c .C r e a t i n i n ew a s
determined by a modified Jaffé reaction using a Beck-
man Synchron LX 20 analyser (Beckman Coulter
GmbH, Krefeld, Germany). This method has an excel-
lent formulation, minimizing interference by protein,
bilirubin and glucose. We measured the concentrations
of RBP by latex immunoassay with a detection and
quantification limits of 0.5 and 2.5 μg/l respectively,
based on a five-fold dilution of urine.
Statistics
Age, body mass index (BMI), duration of exposure and
number of pack-years were described as mean with
standard deviation. Concentrations of biomarkers in
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quartile range (IQR). Associations between biomarkers
and their potential predictors were assessed by Pearson’s
correlation analysis. We used two-way ANOVA to eval-
uate changes in biomarkers associated with working in
smelter, smoking status (never-, ex- and current smo-
ker) and the possible interactions between these two
factors. Comparison between groups of smokers was
performed using the Scheffé’s multiple comparison test
for continuous variables and by the chi-square test for
dichotomic variables. Associations between concentra-
tions of proteins and U-Cd were assessed in stepwise
regression analyses by testing as potential predictors
age, BMI, U-Cd, B-Pb, U-Zn, current smoking, and the
number of pack-years, which were introduced in the
models as dummy variables (pack-years > 1-15 and >
15). We built three models in order to assess the influ-
ence of diuresis on the concentrations of biomarkers
expressed per liter or per g of creatinine. In model 1,
analyses were performed by expressing the concentra-
tions of urinary biomarkers per liter or per g of creati-
nine without any further adjustment for the variable
dilution of urine. In the model 2, the urinary creatinine
was added to the list of potential predictors to adjust for
the influence (concentration per liter) or the residual
influence (concentration per g of creatinine) of diuresis
on the concentrations of urinary proteins. In the model
3, U-Cd expressed per liter or g of creatinine was tested
after a preliminary adjustment for urinary creatinine on
the basis of the simple regression coefficient. The same
analyses were performed with B-Cd at the exception
that only models adjusting the concentrations of pro-
teins in urine were used (models 1 and 2). Independent
variables in multiple regression analyses were entered at
aPv a l u eo f0 . 2 5a n dk e p ti nt h em o d e la tPv a l u e<
0.05. With the exception of age and urinary RBP which
were normally distributed, all variables were normalized
by log transformation. The level of statistical signifi-
cance was set at p < 0.05. Statistical analyses were per-
formed by using SAS version 9.1.3 (SAS International,
Cary, NC).
Results
Table 1 compares the characteristics and biomarker
levels between the smelter and blanket factory workers
stratified according to their smoking status. At the
exception of the blood lead level, which was higher in
smelter workers, there were no significant differences
between the two groups of workers regarding the metal
exposure and renal biomarkers. The only noticeable dif-
ferences concerned current smokers who had signifi-
cantly higher levels of Cd in blood and urine and
Table 1 Characteristics of workers and their biological parameters
Acrylic blanket factory workers Zinc smelter workers Two-way ANOVA
Never-
smokers
Ex-
smokers
Current
smokers
Never-
smokers
Ex-smokers Current
smokers
Occupation Smoking Interaction
N (%) 19 (36.5) 12 (23.1) 21 (40.4) 41 (30.6) 38 (28.4) 55 (41.0)
Age (years) 40.6 (10.1) 42.4 (8.4) 39.6 (8.4) 35.5 (10.1) 42.7 (10.6) 39.0 (10.9) 0.29 0.10 0.36
BMI (kg/m²) 25.1 (3.7) 25.2 (4.0) 23.3 (3.4)* 26.1 (2.9) 25.8 (3.1) 24.3 (3.3)* 0.07 0.004 0.94
Employment
(years)
10.6 (7.3) 12 (8.3) 9.6 (7.1) 9.4 (10.3) 14.7 (8.8) 12.2 (9.3) 0.36 0.22 0.46
Pack-years (N) - 14.9 (9.4) 18.8 (11.8) - 14.2 (7.6) 17.5 (9.20) 0.87 - -
B-Pb (μg/l) 46 (36-58) 55 (44-58) 49 (36-59) 95 (76-137) 89(70-116) 116 (86-143) <0.001 0.51 0.34
B-Cd (μg/l) 0.40 (0.30-
0.45)
0.50 (0.45-
0.85)
0.90 (0.70-
1.23)*
$
0.50 (0.30-
0.70)
0.60 (0.40-
0.80)
1.20 (0.80-
1.70)*
$
0.09 <0.001 0.92
U-Cd (μg/g cr) 0.53 (0.37-
0.68)
0.78 (0.67-
0.90)
0.65 (0.48-
1.02)
0.48 (0.37-
0.81)
0.76 (0.55-
1.18)*
1.00 (0.70-
1.37)*
0.37 <0.001 0.19
U-Zn (mg/g cr) 0.23 (0.18-
0.35)
0.28 (0.27-
0.39)
0.26 (0.21-
0.32)
0.26 (0.16-
0.40)
0.28 (0.21-
0.48)
0.32 (0.20-
0.47)
0.34 0.19 0.38
U-ALB (mg/g cr) 5.4 (3.4-8.5) 6.9 (4.7-9.1) 5.6 (4.0-9.6) 7.9 (5.0-10.8) 8.3 (4.2-12.4) 7.8 (4.7-14.3) 0.09 0.28 0.97
U-Protein-HC (mg/
g cr)
9.3 (5.9-17.4) 15.5 (10.9-
18.6)
13.1 (8.6-22.7) 9.4 (5.5-14.1) 12.6 (8.5-
20.8)
16.0 (9.9-27.5)* 0.82 0.01 0.63
U-RBP (mg/g cr) 120 (91.3-
146)
149 (107-
232)
153 (102-194) 122 (85-161) 123 (90-152) 172 (141-200) 0.74 0.01 0.99
U-Creatinine(g/l) 1.14 (0.91-
1.73)
1.10 (0.94-
1.33)
1.18 (0.95-
1.51)
1.31 (0.88-
1.78)
1.27 (0.85-
1.66)
1.08 (0.78-
1.51)
0.73 0.44 0.77
* significantly different from neversmokers $significantly different from ex-smokers by the test of Tukey-Kramer. Age, body mass index (BMI), duration of
exposure and number of pack-years are given as mean with standard deviation. Concentrations of biomarkers in urine and blood are described as median with
interquartile range (IQR).
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Page 3 of 9excreted also more RBP and protein HC in urine. The
univariate analyses detailed in Table 2 show that urinary
RBP, protein HC and albumin correlate significantly
with urinary Cd. Urinary protein HC was also positively
associated with age and pack-years, two factors which
had no influence on urinary RBP and albumin. Protein
HC and RBP in urine were also associated with Cd in
blood while urinary RBP was associated with lead in
blood. Of note also, the concentrations of Cd and pro-
tein HC in urine, though expressed per gram of creati-
nine, showed negative associations with urinary
creatinine. These associations, illustrated in Figure 1,
mean that expressing these two analytes per g of creati-
nine results in an over-adjustment that does not com-
pletely eliminate the influence of diuresis. The
association between Cd and creatinine in urine, which
was positive with U-Cd expressed per liter (coefficient,
0.60) turned to be negative after adjustment for urinary
creatinine (Figure 1). A similar phenomenon was
observed with urinary protein HC which surprisingly
was already negatively correlated with urinary creatinine
when expressed per liter (coefficient, -0.44).
To account for these residual influences of diuresis on
the concentrations of Cd and proteins in urine, we pur-
sued the analyses by expressing the concentrations of
urinary analytes per liter or per g of creatinine and by
testing different models of adjustment for diuresis.
Table 3 shows that the associations of urinary RBP and
protein HC with U-Cd disappear or loose most of their
statistical significance after adjustment for current
smoking (protein HC) and for the residual influence of
diuresis on the basis of urinary creatinine. Quite unex-
pectedly, the protein which consistently correlated with
U-Cd whatever the model was urinary albumin. These
results were unchanged when testing pack-years or cur-
rent smoking alone or when removing age from the list
of predictors.
To avoid confounding by diuresis, we repeated the
above analyses by using B-Cd as indicator of Cd
exposure. The only significant determinants entering in
the different models (models 1 and 2) were current
smoking for urinary RBP, number of pack-years >15 for
albumin, and B-Cd with age for urinary protein HC.
The association between urinary protein HC and B-Cd
was, however, driven by tobacco smoking for it
Table 2 Pearson’s correlation coefficients between urinary proteins and their potential predictors
Age Log BMI Pack-years Log B-Pb Log B-Cd Log U-Cr Log U-Cd Log U-Zn Log U-RBP Log U-Protein-HC
Log BMI 0.13
Pack-years 0.27*** -0.15*
Log B-Pb -0.05 0.03 -0.02
Log B-Cd -0.08 -0.19* 0.42*** 0.25***
Log U-Cr -0.22** 0.14 -0.10 -0.03 -0.004
Log U-Cd 0.24** -0.18* 0.34*** 0.17* 0.43*** - 0.22**
Log U-Zn -0.02 -0.08 0.08 0.09 0.11 - 0.05 0.16*
Log U-RBP 0.05 0.08 0.14 0.17* 0.26*** -0.14 0.21** 0.03
Log U-Protein-HC 0.23*** 0.02 0.23** -0.01 0.22** -0.34*** 0.23** 0.06 0.45***
Log U-ALB 0.03 -0.004 0.11 0.04 0.14 -0.005 0.15* -0.06 0.29*** 0.31***
For the units of parameters, see Table 1. *p < 0.05, **p < 0.01, ***p < 0.001
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Figure 1 Associations of the creatinine-adjusted concentrations
of protein HC and Cd in urine with the urinary concentration
of creatinine.
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Page 4 of 9completely disappeared after exclusion of smokers. No
association was found between lead in blood and urinary
proteins. After stratification for smoking status, an asso-
ciation emerged between B-Cd and urinary protein HC
in current smokers (p = 0.04) and between urinary RBP
and B-Cd in never smokers (p = 0.02).
The confounding effects of smoking in the assessment
of the renal effects of Cd are illustrated in Figure 2 dis-
playing the relationships of urinary RBP with U-Cd and
B-Cd. To ensure a complete elimination of the influence
of diuresis, the concentration of Cd in urine was
expressed per g of creatinine and further adjusted for
the residual effect of diuresis on the basis of the simple
regression coefficient (Table 2, model 3). Figure 2 clearly
shows that urinary RBP correlates significantly with U-
Cd (p = 0.04) and even more with B-Cd (p = 0.02) only
in never smokers. These associations did not emerge in
ex smokers (p = 0.33 and 0.15) and even less in current
smokers, (p = 0.74 and 0.87, respectively), which clearly
means that the higher urinary excretion of RBP asso-
ciated with smoking cannot be explained by their higher
exposure to Cd. The strong correlations between RBP
and Cd levels in urine and blood observed in the whole
population (Table 2) appear thus to be largely driven by
Table 3 Predictors of RBP, protein HC and albumin in urine according to different modes of expression of results and
adjustment for the residual influence of diuresis
Concentrations of urinary markers per liter Concentrations of urinary markers per g creatinine
Dependent variable Independent variables B 95% CI P Independent variables B 95% CI P
RBP in urine Model 1 Model 1
Log U-Cd 10.7 65.6 to 147.8 <0.001 Current smoking 27.4 9.1 to 46.0 0.004
Log U-Cd 30.9 1.81 to 60.0 0.04
Model 2 Model 2
Current smoking 34.2 10.3 to 58.2 0.005 Current smoking 27.4 9.1 to 46.0 0.004
Log U-Cd 34.7 -3.83 to 73.3 0.08 Log U-Cd 30.9 1.81 to 60.0 0.04
Log U-Cr 285.7 220.0 to 350.6 <0.001
Model 3 Model 3
Current smoking 34.2 10.3 to 58.2 0.005 Current smoking 28.8 10.3 to 47.3 0.003
Log U-Cd adj 34.7 -3.82 to 73.3 0.07 Log U-Cd adj 25.4 -4.5 to 55.2 0.10
Log U-Cr 308.0 248.0 to 367.3 <0.001
Log U-Protein HC Model 1 Model 1
Age 0.009 0.005 to 0.013 <0.001 Age 0.009 0.005 to 0.014 <0.001
Current smoking 0.14 0.054 to 0.22 0.001 Current smoking 0.12 0.02 to 0.22 0.02
Log U-Cd -0.039 -0.16 to 0.086 0.54 Log U-Cd 0.13 -.033 to 0.29 0.12
Model 2 Model 2
Age 0.007 0.003 to 0.011 <0.001 Age 0.008 0.003 to 0.13 0.002
Current smoking 0.11 0.03 to 0.20 0.008 Current smoking 0.011 0.18 to 0.21 0.02
Log U-Cd 0.05 -0.084 to 0.19 0.46 Log U-Cd 0.081 -0.079 to 0.24 0.32
Log U-Cr -0.36 -0.59 to -0.13 0.003 Log U-Cr -0.47 -0.72 to -0.22 <0.001
Model 3 Model 3
Age 0.007 0.003 to 0.011 <0.001 Age 0.008 0.003 to 0.013 0.002
Current smoking 0.11 0.03 to 0.20 0.008 Current smoking 0.011 0.018 to 0.21 0.02
Log U-Cd adj 0.05 -0.084 to 0.19 0.46 Log U-Cd adj 0.081 -0.079 to 0.24 0.32
Log U-Cr -0.33 -0.54 to -0.12 0.003 Log U-Cr -0.52 -0.75 to -0.25 <0.001
Log U-ALB Model 1 Model 1
Log U-Cd 0.39 0.201 to 0.58 <0.001 Log U-Cd 0.19 0.012 to 1.00 0.04
Model 2 Model 2
Log U-Cd 0.20 0.02 to 0.39 0.03 Log U-Cd 0.19 0.012 to 1.00 0.04
Log U-Cr 0.86 0.54 to 1.18 <0.001
Model 3 Model 3
Log U-Cd adj 0.20 0.02 to 0.39 0.03 Log U-Cd adj 0.20 0.016 to 0.39 0.03
Log U-Cr 0.99 0.69 to 1.29 <0.001
U-Cdadj, concentration of Cd expressed per g of creatinine and adjusted for the residual influence of urinary creartinine on the basis of the simple regression
coefficient (Figure 1). The regression coefficients were estimated by stepwise multiple regression analyses testing as predictors age, BMI, Pb in blood, Zn in urine,
current smoking, number of pack-years (>0-15 and >15).
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occur independently in chronic smokers.
We further analyzed our data by examining to what
extent associations between RBP and Cd in urine were
influenced by the integrity of the glomerular or tubular
function. As shown in Figure 3, the associations of RBP
or albumin with Cd in urine completely disappeared in
subjects with increased albuminuria (>90
th percentile or
27 mg/g cr) or increased urinary RBP (>90
th percentile or
220 μg/g cr), respectively (panels C and F in Figure 3).
This phenomenon is not the consequence of differences
in Cd exposure levels between subjects with a normal or
an increased urinary excretion of albumin or RBP.
Indeed, the associations between these two proteins and
U-Cd persist in subjects with exactly the same range of
U-Cd values (0.2-3 μg/g cr) as in subjects with increased
albumin or RBP in urine (Figure 3, panel B and E).
We also tried to assess to what extent the associations
of albumin and RBP with Cd in urine were independent
of each other by mutually adjusting their concentrations
in multiple regression analyses. The association between
RBP and urinary Cd was no more statistically significant
when considering albumin as a potential predictor. Like-
wise, the association between albumin and Cd in urine
disappeared after adjustment for urinary RBP. This
closed interdependence of Cd, RBP and albumin in urine
also emerges from Figure 4 which shows that, plotted on
the same scales, the relationship between RBP and Cd in
urine is almost the replicate of that linking RBP to albu-
min (regression coefficient, 42.5 vs 44.4, respectively).
Discussion
Our study confirms the existence of associations between
urinary Cd and LMW proteins in urine in subjects with
low exposure levels to Cd. These associations, however,
were progressively abolished by the adjustment of LMW
proteins for current smoking, age and the residual influ-
ence of diuresis. We found, however, that the urinary
excretion of Cd was consistently associated with the
excretion of albumin through a relationship, which was
unaffected by diuresis, age or smoking. Stratification of
workers according to the level of urinary albumin or RBP
revealed that these proteins were mutually influencing
their association with urinary Cd. When using blood Cd
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Figure 2 Associations between urinary RBP and the concentrations of Cd in urine or blood in workers stratified in never, ever and
current smokers. Concentrations of Cd in urine, expressed per g of creatinine, have been further adjusted for the residual influence of diuresis
on the basis of the simple regression coefficient between log U-Cd and log urinary creatinine.
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th percentiles of values obtained over the whole population.
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only with urinary RBP but again this association was lar-
gely driven by current smoking. Of note also, in models
based on B-Cd, urinary albumin was associated with
cumulative smoking >15 pack-years.
The increased excretion of LMW proteins is most
probably due to the renal toxicity of tobacco smoke.
Several studies have indeed shown that chronic smok-
ing, even moderate, is associated with an increased urin-
ary excretion of proteins [16-19]. The proteinuria
described in these studies appears to be primarily glo-
merular with a marked increase in the urinary excretion
of albumin. Although in the model based on B-Cd, urin-
ary albumin was increased in workers with the highest
pack-year smoking history, the albumin excretion of
current smokers was on average not different from that
of never smokers. A possible explanation for this lack of
increase in albumin excretion might be that our popula-
tion included relatively few heavy smokers. This is prob-
ably due to the relatively young age of the study
population along perhaps also, especially in smelters, a
healthy worker effect. Our data suggest thus that smok-
ing can cause an impairment of tubular function which
m i g h tb er e v e r s i b l ea si tw a sf o u n do n l yi nc u r r e n tb u t
not in ex-smokers. The component of tobacco smoke
impairing tubular function is unknown but it does not
seem that Cd could be the causative agent. One reason
is that the effect of smoking was found in models
adjusting the LMW protein excretion for the U-Cd
level. The other reason is that LMW proteinuria was
associated only with current smoking and showed no
relationship with number of pack-years, which would
have been expected in case of a chronic effect due to
the accumulation of Cd.
Among the determinants of Cd and protein concen-
trations in urine, the residual influence of diuresis after
adjustment for urinary creatinine appears as the most
confusing one, especially as this factor did not affect
urinary analytes in the same way. The urinary excretion
of RBP and albumin expressed per g of creatinine was
no more correlated with urinary creatinine, meaning
that the adjustment for urinary creatinine completely
eliminates the influence of diuresis. By contrast, the
concentrations of urinary Cd expressed per g of creati-
nine displayed a strong inverse association with urinary
creatinine. Dividing urinary Cd per g of creatinine
results thus in a sort of over-adjustment, which necessi-
tates a correction based on the regression coefficient to
completely eliminate variations linked to diuresis. The
situation is even more confusing with protein HC as the
adjustment for urinary creatinine amplified an associa-
tion with urinary creatinine, which paradoxically was
already negative with protein HC concentrations
expressed per liter. The reasons for these inconsistent
and paradoxical associations of Cd and proteins with
urinary creatinine are unknown. But clearly, the lack of
consideration for these residual influences of diuresis
might generate artifactual associations between Cd and
proteins arising from inaccuracies in the adjustment for
urine dilution.
The finding that associations of RBP and albumin with
U-Cd are abolished in subjects with respectively glomer-
ular and tubular impairment suggests that these associa-
tions are generated by distinct co-excretion mechanisms.
The first mechanism would be an increased excretion to
Cd bound to proteins reabsorbed by the proximal tubule,
in particular to metallothionein, which has been shown
to follow the same glomerular filtration-tubular reabsorp-
tion pathway as other LMW proteins [20]. The associa-
tion between urinary RBP and U-Cd found in subjects
with normal values might thus simply reflect of the phy-
siological variation in the tubular reabsorption capacity
of the proximal tubule. The second co-excretion
mechanism would be an enhanced excretion of Cd
accompanying the albumin excretion. One possibility
would be that Cd is excreted in greater amounts because
of its binding to albumin, the main B-Cdinding protein
in plasma [21]. Another possibility which is suggested by
the similarity of the relationships of RBP with Cd and
albumin in urine, would be a competitive inhibition by
albumin of the tubular reabsorption of LMW proteins,
including Cd-metallothionein. These different mechan-
isms are supported by the experimental evidence that
albumin can competitively inhibit the tubular uptake of
L M Wp r o t e i n ss u c ha sR B Pa n db2-microglobulin
[22,23]. They are also in accordance with our current
understanding of the tubular reabsorption of proteins. It
is now well established that proteins are removed from
the tubular fluid by receptor-mediator endocytosis via
megalin, a receptor known to bind a large variety of pro-
teins, including albumin, metallothionein and the LMW
proteins used for screening tubular proteinuria [24,25].
In conclusion, our study shows that associations of
proteinuria with low-level urinary Cd are largely driven
by current smoking, variations in diuresis and probably
also the co-excretion of Cd with proteins. The mechan-
ism underlying the association between smoking and the
excretion of LMW proteins remains to be elucidated but
our data do not support an implication of Cd.
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